SCHEMBL20150808

SCHEMBL20150808

COc1ccc(/C=N/O)c(F)c1Cl

nearest known ligand 0.44

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
KMT2A Q03164 2/20 0.44
KDM4E B2RXH2 2/20 0.44
L3MBTL1 Q9Y468 2/20 0.44
HPGD P15428 5/20 0.42
TSHR P16473 3/20 0.42
NPC1 O15118 3/20 0.42
RAB9A P51151 3/20 0.42
SMN1; SMN2 Q16637 3/20 0.42
ALDH1A1 P00352 3/20 0.42
NFKB1 P19838 2/20 0.42
NFKB2 Q00653 2/20 0.42
RELA Q04206 2/20 0.42
MEN1 O00255 1/20 0.42
LMNA P02545 2/20 0.40
HTT P42858 2/20 0.40
POLB P06746 1/20 0.37
MAPT P10636 2/20 0.37
CYP1A2 P05177 1/20 0.37
GAA P10253 1/20 0.36
TUBB1 Q9H4B7 2/20 0.36

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL20148160 1.00 KMT2A (0.44) KMT2AKDM4EL3MBTL1HPGDTSHR
SCHEMBL20148159 0.84 HPGD (0.42) KMT2AKDM4EL3MBTL1HPGDTSHR
SCHEMBL20150849 0.84 HPGD (0.42) KMT2AKDM4EL3MBTL1HPGDTSHR
SCHEMBL7370491 0.78 HPGD (0.43) KMT2AKDM4EL3MBTL1HPGDTSHR
SCHEMBL4946236 0.78 POLB (0.57) KMT2AKDM4EL3MBTL1HPGDTSHR
SCHEMBL8731826 0.78 HPGD (0.43) KMT2AKDM4EL3MBTL1HPGDTSHR
SCHEMBL4946232 0.78 POLB (0.57) KMT2AKDM4EL3MBTL1HPGDTSHR
SCHEMBL18508600 0.77 ALDH1A1 (0.38) KMT2AKDM4EL3MBTL1HPGDTSHR
SCHEMBL18502983 0.77 ALDH1A1 (0.38) KMT2AKDM4EL3MBTL1HPGDTSHR
SCHEMBL17858436 0.77 ALDH1A1 (0.46) KMT2AKDM4EL3MBTL1HPGDTSHR

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-10370370-B2 Aminobenzisoxazole compounds as agonists of α7-nicotinic acetylcholine receptors AXOVANT SCIENCES GMBH (CH) 2019-08-06 US disclosed
US-20180134696-A1 Aminobenzisoxazole Compounds as Agonists of Alpha7-Nicotinic Acetylcholine Receptors FORUM PHARMACEUTICALS, INC. 2018-05-17 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-10370370-B2 Aminobenzisoxazole compounds as agonists of α7-nicotinic acetylcholine receptors CHRNA7, CHRNA5, CHRNA2 KMT2A 1703/4885KDM4E 2804/4885L3MBTL1 3046/4885
US-20180134696-A1 Aminobenzisoxazole Compounds as Agonists of Alpha7-Nicotinic Acetylcholine Receptors CHRNA7, CHRNA5, CHRNA2 KMT2A 1939/4885KDM4E 3741/4885L3MBTL1 3492/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.